Skip to main content
Premium Trial:

Request an Annual Quote

Cancer MDx Firm Castle Biosciences Raises $11.8M

NEW YORK (GenomeWeb) – Cancer molecular diagnostics firm Castle Biosciences today said that it raised $11.8 million in a Series E financing round.

The funds will go toward expanding the clinical availability of its diagnostic tests, including DecisionDx-Melanoma for determining the metastatic risk of patients with melanoma, Castle Bio said. Headquartered in Friendswood, Texas, the firm develops molecular diagnostics with a focus on rare cancers. Other tests in its portfolio include those targeting uveal melanoma, cutaneous melanoma, esophageal cancer, thymic cancers, mesothelioma, and gliomas.

New investor HealthQuest Capital led the round and was joined by existing investors, including Mountain Group Capital and affiliates, Longfellow Venture Partners, and others.

In conjunction with the financing HealthQuest Managing Partner Garheng Kong is joining Castle Bio's board.

In May, the company said in a document filed with the US Securities and Exchange Commission that it raised $1 million, and earlier this month, it said that it raised $1.5 million.

According to a Castle Bio spokesman, the $2.5 million was folded into the $11.8 million Series E round.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.